Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,819 | 22,702 | 25,629 | 31,188 | 22,107 |
| Receivables | 115,194 | 120,798 | 124,974 | 127,952 | 130,986 |
| Inventories | 57,784 | 54,496 | 58,241 | 59,773 | 59,031 |
| Other current assets | 7,218 | 6,935 | 8,014 | 8,248 | 6,336 |
| TOTAL | $214,371 | $214,665 | $226,914 | $237,677 | $228,768 |
| Non-Current Assets | |||||
| PPE Net | 99,985 | 99,447 | 98,031 | 97,927 | 97,943 |
| Intangibles | 112,689 | 112,907 | 106,119 | 106,166 | 105,724 |
| Other Non-Current Assets | 160,683 | 156,991 | 160,296 | 160,341 | 159,084 |
| TOTAL | $373,357 | $369,345 | $364,446 | $364,434 | $362,751 |
| Total Assets | $587,728 | $584,010 | $591,360 | $602,111 | $591,519 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,982 | 37,275 | 36,945 | 41,699 | 38,497 |
| Accrued Expenses | 22,295 | 26,525 | 23,363 | 25,319 | 24,049 |
| Other current liabilities | 17,373 | 16,680 | 9,338 | 9,123 | 9,716 |
| TOTAL | $104,734 | $106,015 | $95,743 | $104,772 | $103,727 |
| Non-Current Liabilities | |||||
| Long Term Debt | 114,460 | 110,255 | 114,103 | 124,613 | 124,367 |
| Deferred Revenues | 4,708 | 5,552 | 7,258 | 9,115 | 9,772 |
| Other Non-Current Liabilities | 85,281 | 87,356 | 93,739 | 93,908 | 93,943 |
| TOTAL | $207,850 | $205,787 | $218,229 | $230,036 | $228,436 |
| Total Liabilities | $312,584 | $311,802 | $313,972 | $334,808 | $332,163 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,097 | 46,050 | 46,563 | 46,894 | 46,883 |
| Common Shares | 470 | 470 | 470 | 470 | 470 |
| Retained earnings | 171,413 | 172,662 | 173,598 | 159,824 | 149,657 |
| Other shareholders' equity | 40 | 831 | 446 | 246 | -345 |
| TOTAL | $275,144 | $272,208 | $277,388 | $267,303 | $259,356 |
| Total Liabilities And Equity | $587,728 | $584,010 | $591,360 | $602,111 | $591,519 |